中文
AmbioPharm Inc. Working with University of California Davis to Develop Non-Opioid Peptide-Based Pain Therapeutics
July 20, 2021
READ ARTICLETag: peptide
An Approval for Apellis
June 8, 2021
READ ARTICLE New Peptide Toxin-Derived KV1.3 Channel Inhibitor Publication in the British Journal of Pharmacology
March 2, 2021
READ ARTICLE
New Cyclic Peptides Review
February 9, 2021
READ ARTICLE AmbioPharm Inc. Announces New Shanghai Campus Opening and European Executive Team Members
January 7, 2021
READ ARTICLE
Goodbye 2020: A Peptide Drug Recap and New Webcasts
January 4, 2021
READ ARTICLE
Hope on the Horizon: Covid-19 Vaccine Update and Other Relevant Information
December 2, 2020
READ ARTICLE Covid-19 update at AmbioPharm
March 25, 2020
READ ARTICLE